| JXHL2400260 | BMS-986165片 | deucravacitinib | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2024-11-01 | | Bristol-Myers Squibb Company;BRISTOL-MYERS Squibb (CHINA) Co Ltd | | | view |
| JXHL2400262 | BMS-986165片 | deucravacitinib | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2024-11-01 | | Bristol-Myers Squibb Company;BRISTOL-MYERS Squibb (CHINA) Co Ltd | | | view |
| JXHL2400261 | BMS-986165片 | deucravacitinib | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2024-11-01 | | Bristol-Myers Squibb Company;BRISTOL-MYERS Squibb (CHINA) Co Ltd | | | view |
| JXHB2400101 | BMS-986165片 | deucravacitinib | Tablet | Chemical Drugs | Supplementary Application | 2024-06-14 | | Bristol-Myers Squibb Company;Patheon Inc | | | view |
| JXHB2300166 | BMS-986165片 | deucravacitinib | Tablet | Chemical Drugs(2.4) | Supplementary Application | 2023-10-21 | | Bristol-Myers Squibb Company | | | view |
| JXHL2300136 | BMS-986165片 | deucravacitinib | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2023-06-02 | | Bristol-Myers Squibb Company;BRISTOL-MYERS Squibb (CHINA) Co Ltd | | | view |
| JXHL2300135 | BMS-986165片 | deucravacitinib | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2023-06-02 | | Bristol-Myers Squibb Company;BRISTOL-MYERS Squibb (CHINA) Co Ltd | | | view |
| JXHL2200310 | BMS-986165片 | deucravacitinib | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2022-10-22 | | Bristol-Myers Squibb Company;BRISTOL-MYERS Squibb (CHINA) Co Ltd | | | view |
| JXHB2200113 | BMS-986165片 | deucravacitinib | Tablet | Chemical Drugs(1) | Supplementary Application | 2022-08-15 | | Bristol-Myers Squibb Company;Patheon Inc | | | view |
| JXHB2200114 | BMS-986165片 | deucravacitinib | Tablet | Chemical Drugs(1) | Supplementary Application | 2022-08-15 | | Bristol-Myers Squibb Company;Patheon Inc | | | view |
| JXHB2101091 | BMS-986165片 | deucravacitinib | Tablet | Chemical Drugs(1) | Supplementary Application | 2021-11-09 | | Bristol-Myers Squibb Company;Patheon Inc | | | view |
| JXHL2101074 | BMS-986165片 | deucravacitinib | Tablet | Chemical Drugs(1) | Import Drug Application | 2021-06-01 | | Bristol-Myers Squibb Company | | | view |
| JXHL2101073 | BMS-986165片 | deucravacitinib | Tablet | Chemical Drugs(1) | Import Drug Application | 2021-06-01 | | Bristol-Myers Squibb Company | | | view |
| JXHL2101075 | BMS-986165片 | deucravacitinib | Tablet | Chemical Drugs(1) | Import Drug Application | 2021-06-01 | | Bristol-Myers Squibb Company | | | view |
| JXHB2000060 | BMS-986165片 | deucravacitinib | Tablet | Chemical Drugs(1) | Supplementary Application | 2020-12-25 | 百时美施贵宝（中国）投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd;Piramal Healthcare Uk Ltd;Bristol-Myers Squibb Company | In Review | 2020-12-23 | view |
| JXHB2000061 | BMS-986165片 | deucravacitinib | Tablet | Chemical Drugs(1) | Supplementary Application | 2020-12-18 | 百时美施贵宝（中国）投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd;Piramal Healthcare Uk Ltd;Bristol-Myers Squibb Company | In Review | 2020-12-17 | view |
| JXHB2000030 | BMS-986165片 | deucravacitinib | Tablet | Chemical Drugs(1) | Supplementary Application | 2020-09-23 | 百时美施贵宝（中国）投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd;Piramal Healthcare Uk Ltd;Bristol-Myers Squibb Company | In Review | 2020-09-22 | view |
| JXHB2000029 | BMS-986165片 | deucravacitinib | Tablet | Chemical Drugs(1) | Supplementary Application | 2020-09-23 | 百时美施贵宝（中国）投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd;Piramal Healthcare Uk Ltd;Bristol-Myers Squibb Company | In Review | 2020-09-22 | view |
| JXHL1900279 | BMS-986165片 | deucravacitinib | Tablet | Chemical Drugs(1) | Import Drug Application | 2019-11-01 | 百时美施贵宝（中国）投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd;Bristol-Myers Squibb Company | In Review | 2019-10-31 | view |
| JXHL1900133 | BMS-986165片 | deucravacitinib | Tablet | Chemical Drugs(1) | Import Drug Application | 2019-06-17 | 百时美施贵宝（中国）投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd;Bristol-Myers Squibb Company | In Review | 2019-06-14 | view |
